Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008
Date:8/6/2008

ditionally, current quarter margins were negatively impacted by competition on certain products including amlodipine and oxybutynin during the past twelve months.

The Company reported earnings from operations of $74.0 million for the three months ended June 30, 2008. Excluding the purchase accounting items discussed above, earnings from operations would have been $186.1 million.

For the quarter ended June 30, 2007, Mylan reported earnings from operations of $188.1 million. Excluding certain purchase accounting items, earnings from operations would have been $206.9 million. This represents a current year decrease of $20.8 million or 10.0%, which is the result of increased research and development ("R&D") expense and selling, general and administrative ("SG&A") expense.

R&D expense was $80.8 million for the three months ended June 30, 2008, compared to $31.7 million in the same prior year period. R&D expense includes approximately $40.9 million related to newly acquired entities, all of which was incremental to the comparable prior year period. Excluding this amount, R&D expense increased by $8.1 million or 26% primarily as a result of increased ANDA submissions.

SG&A expense for the three months ended June 30, 2008 was $259.5 million compared to $76.9 million in the same prior year period. SG&A expense includes approximately $152.9 million related to newly acquired entities, all of which was incremental to the comparable prior year period. Excluding this amount, SG&A expense increased by $29.5 million or 38%. The majority of this increase was realized by Corporate and Other, and is the result of costs associated with the integration of Merck Generics, as well as higher payroll and related costs principally attributable to the build-up of additional corporate infrastructure as a direct result of the acquisition.

Interest expense for the current quarter totaled $86.5 million compared to $22.9 million for the three months ended June 30
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Mylan Announces Final FDA Approval for Carvedilol Tablets
3. Mylan Announces Tentative FDA Approval for Topiramate Capsules
4. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
5. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
8. Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
9. Mylan Announces Appointment of Harry A. Korman as President, North America
10. Mylan Announces Appointment of John Montgomery as President, Asia Pacific
11. Mylan Announces Management of Specialty Business, Dey L.P.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... are chemical substances, which are able to kill unwanted ... prevent degradation of the physical and sensorial properties of ... used in various applications such as water treatment, personal ... It is also used in domestic applications such as ... to prevent fouling in water and oil pipelines. , ...
(Date:7/29/2014)... use of electronic medical records and health information ... computerized version of the preventive care guidelines pediatricians ... study, researchers from the Indiana University School of ... work lies ahead to convert the American Academy ... for physicians, but the payoff has the potential ...
(Date:7/29/2014)... 29, 2014 The Latin American poultry feed ... with analysis and forecast of revenue. The poultry feed and ... from $25,273.3 million and $647.2 million in 2013 to $34,024.0 ... 6.1% from 2013 to 2018, respectively. , To get an ... the TOC of the Latin American poultry feed and feed ...
(Date:7/29/2014)... HealthDay Reporter MONDAY, July 28, ... continues to rage throughout West Africa poses little risk to ... through physical touch, and it can,t be spread by people ... of the National Center for Emerging & Zoonotic Infectious Diseases ... in a Monday afternoon news conference. Those factors -- ...
(Date:7/29/2014)... including Penn State College of Medicine, have jointly ... a health data research network., The Patient-Centered Outcomes ... Patient Protection and Affordable Care Act, awarded the ... University and Johns Hopkins University -- and each ... have come together to create a Clinical Data ...
Breaking Medicine News(10 mins):Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 4Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 2Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 3Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Poultry Feed Market is Expected to Reach $870.1 Million in 2018 - New Report by MicroMarket Monitor 5Health News:CDC Downplays Ebola's Threat to the United States 2Health News:CDC Downplays Ebola's Threat to the United States 3Health News:CDC Downplays Ebola's Threat to the United States 4Health News:New network unites university health care research 2
... sickle cell disease who also have lower blood oxygen ... have heart abnormalities, researchers at Washington University School of ... Heart problems are fairly common in young adults ... why. The researchers demonstrated that lower oxygen saturation in ...
... ... (radial Keratotomy) may benifit from PRELEX with crystalens according to Dr. Khanna. , ... (Vocus) April 27, 2010 -- Patents that ... Khanna. Radial Keratotomy was in vogue in the late seventy’s and eighties. Its popularity declined ...
... function , TUESDAY, April 27 (HealthDay News) -- High-dose ... and patients on this regimen should stop immediately, says a ... believed it would show that high-dose vitamin B therapy (folic ... function and reduce their risk of heart attack and stroke. ...
... study finds problems contracting, relaxing, , TUESDAY, April 27 ... the heart more than had been thought, a new ... what might be the first clear evidence that these ... damage heart function, said Dr. Aaron L. Baggish, an ...
... Digestive Health and Nutrition (FDHN) announced this year,s recipient ... Kenneth P. Olive, PhD. The $225,000 gift from ... with funding and protected time for three years to ... Schwartz, a businessman and photographer, suffered from the disease ...
... ... to select their perfect retirement community based on community culture, personality, amenities and personal preferences. ... Princeton, NJ (PRWEB) ... can be a complicated, confusing chore. In fact, retirees and their families must choose ...
Cached Medicine News:Health News:Low blood oxygen may lead to heart defects in children with sickle cell disease 2Health News:Low blood oxygen may lead to heart defects in children with sickle cell disease 3Health News:Crystalens HD May Help People with RK 2Health News:Steroids Could Harm Heart's Pumping Ability 2Health News:Steroids Could Harm Heart's Pumping Ability 3Health News:Second AGA Foundation/Bernard Lee Schwartz Foundation Research Scholar Award presented 2Health News:RetiringbyDesign.com Offers Retirees a Smarter Way to Explore Living Options 2Health News:RetiringbyDesign.com Offers Retirees a Smarter Way to Explore Living Options 3
(Date:7/29/2014)... NEW YORK , July 29, 2014 /PRNewswire/ ... team of Caremark Rx, Drew Crawford today ... PBM365 is the leading independent media source dedicated to ... and opinion on the pharmacy benefit management (PBM) industry ... timely coverage of, and context behind, industry news.   The ...
(Date:7/29/2014)... July 29, 2014  Roche (SIX: RO, ROG; OTCQX: ... Clinical Chemistry (AACC) 2014 Clinical Lab Expo today by ... unique ways Roche is partnering with customers to redefine ... tell us every day that they,re looking for a ... in their labs and offices," said Jack Phillips ...
(Date:7/29/2014)... Laboratory (IL) today announced the launch of its new corporate ... of a comprehensive rebranding effort by Werfen, the parent company ... , in 1959, IL has been part of the ... the group include Inova Diagnostics ( San Diego, CA ... ).  Like IL, these three companies are focused on ...
Breaking Medicine Technology:Drew Crawford Announces Launch of PBM365 Media 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Instrumentation Laboratory Unveils New Corporate Brand 2Instrumentation Laboratory Unveils New Corporate Brand 3
... 2007 -,Icagen, Inc. (NASDAQ: ICGN) today announced that ... at the C.E. Unterberg,Towbin Emerging Growth Opportunities Conference ... 2:00 p.m. ET., There will be a live ... will be accessible through a link posted on,the ...
... --,SuperGen, Inc. today announced that Dr. Gregory Berk, ... Towbin Emerging Growth,Opportunities Conference on Thursday, July 12, ... City. , SuperGen's presentation at the C.E. Unterberg, ... at 3:30 p.m.,EDT. A live webcast of the ...
Cached Medicine Technology:Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2SuperGen to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2
Multi-constituent normal and abnormal plasma controls for routine and specialty assays performed on the STA© family of hemostasis analyzers....
PT, PTT, Fibrinogetn & TT Normal and Abnormal Controls...
Fructosamine Calibrator...
ApolipoproteinA-1 & B Calibrator...
Medicine Products: